Group One Trading’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
|
|||||
|
2025
Q1 | – | Hold |
|
|||||
|
2024
Q4 | – | Hold |
|
|||||
|
2024
Q3 | – | Hold |
|
|||||
|
2024
Q2 | – | Hold |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $27.3K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $262K | Sell |
|
|||||
|
2023
Q1 | $300K | Sell |
|
|||||
|
2022
Q4 | $1.58M | Sell |
|
|||||
|
2022
Q3 | $1.94M | Buy |
|
|||||
|
2022
Q2 | $1.37M | Buy |
|
|||||
|
2022
Q1 | $578K | Buy |
|
|||||
|
2021
Q4 | $337K | Sell |
|
|||||
|
2021
Q3 | $633K | Sell |
|
|||||
|
2021
Q2 | $3.29M | Buy |
|
|||||
|
2021
Q1 | $465K | Sell |
|
|||||
|
2020
Q4 | $343K | Buy |
|
|||||
|
2020
Q3 | $131K | Sell |
|
|||||
|
2020
Q2 | $317K | Sell |
|
|||||
|
2020
Q1 | $222K | Sell |
|
|||||
|
2019
Q4 | $282K | Sell |
|
|||||
|
2019
Q3 | $375K | Sell |
|
|||||
|
2019
Q2 | $422K | Buy |
|
|||||
|
2019
Q1 | $277K | Sell |
|
|||||
|
2018
Q4 | $231K | Buy |
|
|||||
|
2018
Q3 | $328K | Sell |
|
|||||
|
2018
Q2 | $362K | Buy |
|
|||||
|
2018
Q1 | $365K | Buy |
|
|||||
|
2017
Q4 | $302K | Buy |
|
|||||
|
2017
Q3 | $317K | Buy |
|
|||||
|
2017
Q2 | $89K | Buy |
|
|||||
|
2017
Q1 | $49K | Sell |
|
|||||
|
2016
Q4 | $91K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $158K | Buy |
|
|||||
|
2016
Q1 | $88K | Buy |
|
|||||
|
2015
Q4 | $24K | Buy |
|